Cheminformatic Tools and Databases for Pharmacology

session 72803 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
VORTIOXETINE

VORTIOXETINE


ATC N06AX26

NERVOUS SYSTEM
TREATMENT OF MAJOR DEPRESSIVE DISORDER
ENHANCEMENT OF SEROTONERGIC ACTIVITY
INHIBITION OF THE REUPTAKE OF SEROTONIN (5-HT)
SEROTONIN TRANSPORTER INHIBITOR (KI=1.6 NANOMOLAR)
5-HT3 RECEPTOR ANTAGONIST (KI=3.7 NANOMOLAR) AND 5-HT1A RECEPTOR AGONIST (KI=15 NANOMOLAR), 5-HT7 (KI=19 NM), 5-HT1D (KI=54 NM), AND 5-HT1B (KI=33 NM), RECEPTORS AND IS A 5-HT3, 5-HT1D, AND 5-HT7 RECEPTOR ANTAGONIST, 5-HT1B RECEPTOR PARTIAL AGONIST, AND 5-HT1A RECEPTOR AGONIST.

ORAL

Cmax 110 NANOMOLAR

F 75 PERCENT

VD 2600 LITER

PPB 98 PERCENT

Cl 27.3 LITER / HOUR (EQN)

HT 66 HOUR

SOLUBILITY SLIGHTLY SOLUBLE IN WATER

SEROTONIN TRANSPORTER

SEROTONIN 1A (5-HT1A) RECEPTOR AGONIST CHEMBL214 SEROTONIN 1A (5-HT1A) RECEPTOR P08908 5-HYDROXYTRYPTAMINE RECEPTOR 1A HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR SEROTONIN RECEPTORANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |